NOTE PURCHASE AGREEMENT by and between PFIZER INC. and MONOGRAM BIOSCIENCES, INC. Dated as of May 5, 2006Note Purchase Agreement • June 16th, 2006 • Monogram Biosciences, Inc. • In vitro & in vivo diagnostic substances • New York
THIS NOTE PURCHASE AGREEMENT (“Agreement”) is made as of May 5, 2006 (the “Effective Date”), by and between MONOGRAM BIOSCIENCES, INC., a Delaware corporation with its principal place of business at 345 Oyster Point Boulevard, South San Francisco, California 94080 (the “Company”), and PFIZER INC., 235 East 42nd Street, New York, NY 10017 (subject to Section 11.10(a), the “Purchaser”).
NOTE SECURITY AGREEMENTNote Security Agreement • June 16th, 2006 • Monogram Biosciences, Inc. • In vitro & in vivo diagnostic substances • New York
This Note Security Agreement (this “Agreement”) is made and entered into as of May 5, 2006 by and between Monogram Biosciences, Inc. (the “Grantor”), and Pfizer Inc. (the “Secured Party”).
